SEMPRUS BioSciences Closes $8M Series A Financing
Summary
SEMPRUS BioSciences closed an $8 million Series A financing round led by 5AM Ventures and Pangaea Ventures. The company develops a surface technology platform that reduces complications in medical devices, including infections and thrombosis. It plans to use the capital to advance its product candidates and expand development efforts. The article also highlights the company’s value proposition for hospitals, device users, and the broader medical device market.
Funding
Amount
$8.0M
Total raised
Date
December 12, 2008
Announcement date
Investors
Wyss Institute, Pangaea Ventures, 5AM Ventures, MIT Global Founders' Skills Accelerator
Lead investors
Company
semprusbio.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected